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NRF-1HHcy has been implicated in elderly frailty, but the underlying mechanisms are poorly understood. Using C57
and CBS+/− mice and C2C12 cell line, we investigated mechanisms behind HHcy induced skeletal muscle
weakness and fatigability. Possible alterations in metabolic capacity (levels of LDH, CS, MM-CK and COX-IV), in
structural proteins (levels of dystrophin) and in mitochondrial function (ATP production) were examined. An
exercise regimen was employed to reverse HHcy induced changes. CBS+/− mice exhibited more fatigability,
and generated less contraction force. No signiﬁcant changes in muscle morphology were observed. However,
there is a corresponding reduction in large muscle ﬁber number in CBS+/− mice. Excess fatigability was not
due to changes in key enzymes involved inmetabolism, but was due to reduced ATP levels. Amarginal reduction
in dystrophin levels along with a decrease inmitochondrial transcription factor A (mtTFA)were observed. There
was also an increase in the mir-31, and mir-494 quantities that were implicated in dystrophin and mtTFA
regulation respectively. The molecular changes elevated during HHcy, with the exception of dystrophin levels,
were reversed after exercise. In addition, the amount of NRF-1, one of the transcriptional regulators of mtTFA,
was signiﬁcantly decreased. Furthermore, there was enhancement in mir-494 levels and a concomitant decline
in mtTFA protein quantity in homocysteine treated cells. These changes in C2C12 cells were also accompanied
by an increase in DNMT3a and DNMT3b proteins and global DNA methylation levels. Together, these results
suggest that HHcy plays a causal role in enhanced fatigability throughmitochondrial dysfunction which involves
epigenetic changes.
Published by Elsevier B.V.1. Introduction
Impaired cardiovascular function and derailed energy metabolism
(as in diabetes and obesity) are the twomajor causes for humanmortal-
ity and morbidity in the 21st century [1–3]. Exercise has been shown to
correct both metabolic impairments and cardiovascular deﬁciencies
[4–6]. However, exercise intolerance and fatigue are the leading causes
that undermine the beneﬁts of exercise in apparently physically normal
individuals [7]. Furthermore, certain factors such as hyperhomocystei-
nemia aggravate age associated decline in physical function [8]. In this
regard, understanding molecular changes associated with the factors
that cause fatigue or exercise intolerance not only beneﬁt efforts
that raise physical capabilities, but also signiﬁcantly reduces mortalitynsferase; CBS, cystathionine β-
steine; mtTFA, mitochondrial
one H3 lysine 18; LDH, lactate
e C oxidase subunit IV; 5-mC, 5
ed receptor-gamma coactivator
sferase;NRF,nuclearrespiratory
.and morbidity associated with cardiovascular disease and metabolic
syndromes such as diabetes and obesity through improved exercise
competence.
Fatigue could result from decreased muscle mass and/or structural
and metabolic/energy production alterations intrinsic to muscle cells
[9]. Structural alterations that lead to progressive muscle weakness
are well characterized. Of note are the defects associated with dystro-
phin complex assembly [10]. Dystrophin anchors the inner cytoskeleton
to the outermatrix via a dystrophin complex and is perceived to provide
membrane stabilization, especially during rigorous muscle contractions
[10–12]. Dystrophin deﬁciency was proposed to cause muscle mem-
brane injury during exercise and limits exercise capacity [11]. Other de-
ﬁciencies in structural proteins are also reported [11]. While genetic
causes underlying changes in dystrophin and other important structural
components, such as truncated protein products and defective splicing,
are relatively well characterized, involvement of epigenetic modiﬁca-
tions is less well characterized [13].
Apart from structural deﬁciencies, energy imbalances were also
reported to play a crucial role in causation of fatigue [14,15]. As mito-
chondria play a pivotal role in the production of bulk cellular ATP, the
cellular currency, the factors that either compromise mitochondrial
function and/or prevent mitochondrial biogenesis and content would
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regulators of mitochondrial gene transcription and mitochondrial DNA
replication such as mitochondrial transcription factors (mtTF), nuclear
encoded mitochondrial localized proteins, have been reported to
cause exercise intolerance and fatigue in mouse models [16]. Moreover
changes in genes that regulate aerobic and anaerobic metabolism have
also been implicated in causation of exercise intolerance [19]. For exam-
ple, alterations in CS, LDH and COX-IV were reported to limit physical
capacity [19–22]. Identiﬁcation of factors that cause mitochondrial
dysfunction and/or declined biogenesis as well as changes in energy
metabolism is necessary to enhance physical capacity and to maximize
exercise beneﬁts.
Recent evidence suggests that epigenetics can also modulate gene
expression levels through changes in DNA methylation, regulation of
chromatin structure and gene accessibility and most recently through
microRNA expression levels [23–25]. Though involvement of epigenetic
modiﬁcations in regulation of important gene expression levels associ-
ated with skeletal muscle function are characterized relatively well
[26], the role of epigeneticmodiﬁcations in causation of fatigue is largely
unknown [13]. Importantly knowledge regarding pathological factors
that contribute to fatigue and associated epigenetic modiﬁcations is
lacking. In the current study we evaluated the inﬂuence of hyperhomo-
cysteinemia (HHcy) on skeletal muscle fatigability and associated
epigenetic modiﬁcations.
HHcy is a metabolic disorder mainly due to improper removal and/
or accumulation of the non-protein coding sulfur containing amino
acid homocysteine (Hcy) [8]. Genetic, nutritional and disease speciﬁc
factors have been implicated in causation of HHcy [8]. Though skeletal
muscle deformities in HHcy patients have been reported long ago [27],
it is now that the association between HHcy and decline inmuscle func-
tion is increasingly recognized [8]. However, the causes for such a de-
cline in physical function are not well characterized [8]. As Hcy
metabolism also generatesmethyl groups to feed to the cellularmethyl-
ation reactions and DNA methylation is aberrant in HHcy conditions,
HHcy is proposed as an epigenetic modulator [8]. However, the rele-
vance of epigenetic changes during HHcy in causation of muscle
weakness is not known. In the current study we have characterized
the nature of HHcy medicated changes in skeletal muscle function and
found that epigenetic modiﬁcations contribute to HHcy associated
decline in physical function using genetic mouse models of HHcy. The
transsulfuration enzyme CBS, Cystathionine β synthase which performs
irreversible conversion of Hcy into cysteine, has been found to be
frequently mutated in human beings. Consequently, mouse models
that lack CBS had been generated. The homozygous CBS knock out
mice not only exhibit severe HHcy, but also die shortly after birth [28].
Hence, themice heterozygous for CBS gene depletion, exhibit moderate
HHcy with normal longevity, and are frequently used to know the
systemic effects of HHcy condition [8,28]. In the current study, the
CBS+/−mice exhibited more fatigability, and generated less contrac-
tion force. No signiﬁcant changes inmusclemorphologywere observed.
However, there is a corresponding reduction in large muscle ﬁber
number in CBS+/− mice. Excess fatigability was not due to changes
in key enzymes involved in metabolism, but was due to reduced ATP
levels. A marginal reduction in dystrophin levels along with a decrease
in mitochondrial transcription factor A (mtTFA) were observed. There
was also an increase in the mir-31, and mir-494 quantities that were
implicated in dystrophin andmtTFA regulation respectively. Themolec-
ular changes elevated during HHcy, with the exception of dystrophin
levels, were reversed in CBS+/− mice after exercise. In addition, the
amount of NRF-1, one of the transcriptional regulators of mtTFA, was
signiﬁcantly decreased in CBS+/− mice. Furthermore, after treating
C2C12 cells with homocysteine (Hcy), there was enhancement in mir-
494 levels and concomitant decline in mtTFA protein amount. These
changes in C2C12 cells were also accompanied by an increase in
DNMT3a and DNMT3b proteins and global DNA methylation levels.
Together, these results suggest that HHcy plays a causal role in reducedphysical performance and muscle force generation through mitochon-
drial dysfunction which involve epigenetic changes.
2. Materials and methods
2.1. Ex-vivo muscle contraction
Myobath studies were conducted using multi-channel isolated
tissue bath system as described before [29] (Myobath, World Precision
Instruments, Sarasota, FL, USA). All in vivo conditions such as tempera-
ture (37 °C), pH, electrolyte strength and proper aerationwere supplied.
The desired muscles were isolated from tendon to tendon without
damage to the muscle bundle. Isolated intact muscles were mounted
onto a force transducer and muscle contractions were recorded after
determining the appropriate tension. For each experiment initial mus-
cle tension was adjusted to give maximal response. Duration of muscle
contraction for a given stimulus and maximal response were calculated
after supplying ﬁeld electric stimulus. As there were no signiﬁcant
measurable differences between weight and length of EDL and soleus
from different groups no normalization was done to reﬂect the weight
and length of the muscles. All the muscles were stimulated with 40 V
(maximal electric output) for a duration of 30 ms (milliseconds) with
a frequency of 0.5 Hz.
2.2. Exercise protocol
Allmice in the exercise groupwere administered a swimmingproto-
col, aerobic endurance exercise, developed from recommendations
listed in the “Resource Book for theDesign of Animal Exercise Protocols”
by the American Physiological Society. The protocol consisted of 4 days
of exercise per week for 4 weeks with the duration of swimming
starting at 30 min on week 1 and increasing by 15 min each week to a
maximum duration of 75 min by the fourth week. Large polymer con-
tainers measuring 20 in. × 14 in. × 7 in. were ﬁlled with warm water
to a depth of approximately 5 in. The water temperature was main-
tained between 32 and 36 °Celsius. Mice were placed in the water and
constantly monitored to ensure safety and physical activity. If the
mice discontinued swimming for more than 2 s, they were gently
nudged to promote movement. Upon completion of exercise, the mice
were placed on a paper towel and gently dried off before being placed
back into their cage.
2.3. Swim test
Intact male mice of appropriate ages fromWT and CBS−/+ groups
were subjected to swim performance and the live recordings were
obtained using ‘Live animal behavior recoding and analysis system’
(Topscan) from CLEVER SYSTEMS (Reston, Virginia, USA) as described
before [30].
2.4. Tissue ATP estimation
Desired tissues (entire soleus muscle) were snap frozen and were
used later for enumeration of ATP levels. Total ATP levels were
measured using calorimetric kit from Bio Vision (Milpitas, CA, USA).
Cold homogenized tissues were deproteinized and neutralized as
described in the kit. Cleared samples were used to assay for the ATP
levels using spectromaxx spectrophotometer with appropriate stan-
dards. Tissue ATP levels were derived from standard curve equations.
2.5. Global methyl-C estimation
Genomic DNA was isolated using Quick-gDNA™MiniPrep kit from
Zymo Research (Irvine, CA, USA). After quantiﬁcation, an equal amount
of genomic DNAwas used to estimate global levels of 5-methylcytosine
Fig. 1. Summary of live recording of intact WT and CBS+/−mice motion performance
during swim test. (A) Representative animal tracings were shown for the ﬁrst 10 min of
swim for each group. (B) Box plot depicting measurements of total distance moved
(mm) for a given period of 20 min was measured for each group. N = 6 and * indicates
p b 0.05. (C) Box plot representing measurement of fatigue susceptibility as expressed
here as time spent with motion speeds less than 5 mm/s. N = 6 and * indicates p b 0.05.
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following the manufacturer's instructions.
2.6. Real time PCR
Total RNAwas isolated fromdifferent samples and quality and quan-
titywere assessedusing a spectro-photometer (NanoDrop,Wilmington,
DE, USA). Total cDNA was synthesized using Hiﬂex buffer reagent
system (miScript II RT kit) from Qiagen (Gaithersburg, MD, USA) by
following the manufacturer's instructions. The following primers (5′ to
3′) were used to amplify the mRNA of interest using RT SYBER green
qPCR master mix (Qiagen, Gaithersburg, MD, USA): b-Actin F (5′–3′):
GGCTGTATTCCCCTCCATCG, R: CCAGTTGGTAACAATGCCATGT; CS F
(5′–3′): GGACAATTTTCCAACCAATCTGC, R: TCGGTTCATTCCCTCTGC
ATA; COX-IV F: ATTGGCAAGAGAGCCATTTCTAC, R: CACGCCGATCAGCG
TAAGT; LDH F: TGTCTCCAGCAAAGACTACTGT, R: GACTGTACTTGACA
ATGTTGGGA. NRF-1 F: TATGGCGGAAGTAATGAAAGACG, R: CAACGTAA
GCTCTGCCTTGTT. MM-CK F: CTGACCCCTGACCTCTACAAT, R: CATGGC
GGTCCTGGATGAT. For estimation of levels of miRNA of interest
we used miScript primer assay system in combination with universal
primer (Qiagen, Gaithersburg,MD, USA). Datawas analyzed by calculat-
ing normalized relative ratios using cq values.
2.7. Western blotting
Whole cell lysates fromhomogenized tissues and cultured cellswere
prepared using RIPA lysis buffer containing protease and phosphatase
inhibitors as described earlier [30]. After lysis with the buffer, the prep-
arations were subjected to sonication. Cleared supernatants were
obtained after centrifugation. Protein quantities among different sam-
ples were determined using Bio-Rad Bradford reagent. Equal quantities
of protein samples were resolved using SDS-PAGE gel as described
before [30]. After probing the membranes with primary and secondary
antibodies along with appropriate washes, chemiluminescence signal
was detected using Bio-Rad ChemiDoc™ XRS+ System and Image
Lab™ Software (Bio-Rad, Hercules, CA, USA).
2.8. Antibodies
The antibody sources are: anti-mtTFA from Santa Cruz, (Paso Robles,
CA, USA); anti-Mfn2, anti-H3K18 acetylation, anti-DNMT3a, anti-
DNMT3b and anti-Dystrophin from Abcam (Cambridge, MA, USA);
and anti-GAPDH from Millipore (Billerica, MA, USA). HRP conjugated
secondary antibodies were purchased from Santa Cruz Biotechnology
(Dallas, Texas, USA).
2.9. Hematoxylin and eosin (H & E) staining and enumeration of muscle
ﬁber cross sectional area (CSA)
Frozen sections of gastrocnemius muscle were subjected to H & E
staining as described before [31]. A minimum of 4 different animals
from each group was used. Pictures were obtained using cooled Q
imaging camera. A minimum of 350 ﬁbers was used to measure CSA
for each group using ImageJ software [31].
2.10. Animal care and tissue collection
WT (C57BL/6J) and CBS−/+ (B6.129P2-Cbstm1Unc/J 002853) mice
were genotyped and reared on regular chow andwater as reported pre-
viously [30]. All the animal studies were approved by the institutional
IACUC and are in conformitywith the prescribed institutional standards.
Standard procedures were followed for collection of tissues and for
isolation of individual muscles for ex-vivo contraction experiments
after induction of general anesthesia using tribromoethanol as
described before [32]. Except for Figs. 3B, 4, and 5 we used male mice.For these ﬁgures we included male and female mice of similar age
groups.
2.11. Cell culture
C2C12 cells were grown using DMEM medium (life technologies)
with 10% FBS and 1% penicillin and streptomycin solution. At a
conﬂuence of 80%, the cells were subjected to differentiation using
DMEM medium (ATCC) containing 2% horse serum and 1% penicillin
and streptomycin solution. After 5 days of differentiation, cells were
treated with Hcy (500 μM) (Sigma-Aldrich, St. Louis, MO, USA) for 3
consecutive days with appropriate control. At the end of the treatment
cell were lysed and protein, total RNA and DNA were collected.
2.12. Statistical analysis
Images from theWestern blottingwere obtained and analyzed using
Image lab (Bio-Rad, Hercules, CA, USA) software. P value b 0.05 was
considered signiﬁcant. The Student t-test was used to enumerate the
levels of signiﬁcance between two different groups. For quantiﬁcation
and analysis of Q-PCR data, we used light cycler software from Roche.
Unless otherwise mentioned a minimum of 3 replicates was used for
the studies.
3. Results
3.1. HHcy alters whole animal performance
Previous studies reported that there was considerable decline in
body weight of HHcy mice [33]. Moreover, recently it was proposed
that lack of prompt revascularization after ischemic events could poten-
tially undermine the skeletal muscle performance [34]. However, actual
functional capacity of the intact animals was not assessed. In order to
verify if there are any alterations in exercise capacity or functional per-
formance, we measured various parameters such as total distance
moved in a given time and fatigability after subjecting the intact mice
from age matched wild type (WT) and CBS+/− groups through swim
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tance moved in a given time and speed of motion revealed that there
was signiﬁcant reduction in total distance covered in a given time and
enhancement in fatigue levels during the course with the CBS+/−
mice when compared to WT mice (Fig. 1A, B and C). The rate of motion
was high at the beginning of the swim challenge for all the participants
suggesting that both the groups have healthy animals. During the ﬁrst
20 min (bar graphs), the CBS+/−mice could move only half the dis-
tance as the wild type mice. The CBS+/− mice also spent relatively
higher amount of time with slow speed (b5 mm/s) compared to the
wild type controls. These results suggested that HHcy could potentially
compromise total distancemoved in a given time and also affectmotion
speed which may suggest enhanced fatigability.
3.2. Altered ex-vivo muscle contraction of oxidative and glycolytic skeletal
muscles from CBS+/−mice
Enhanced fatigability that was observed with the CBS+/− mice
could result from many pathological processes affecting different
organ systems and does not itself indicate defective skeletal muscle
function per se. Hence, we elected to characterize if HHcy could
alter skeletal muscle function by subjecting isolated intact muscles
from anesthetized mice for ﬁeld electric stimulation in a myobath
chamber that mimics endogenous physiological conditions. We used
both oxidative/slow twitch (soleus) and glycolytic/fast-twitch (exten-
sor digitorum longus, EDL) muscles to measure ex-vivo contractile
properties. As shown in Fig. 2, the EDL muscles from both groups
exhibited higher contractile forcewhen compared to the force produced
from soleus muscles. However, soleus muscles could contract for aFig. 2. Summary of ex-vivo isometricmuscle contraction response to ﬁeld stimulation inmyobat
respectively for both groups are shown. X-axis represents time (min) and Y-axis represent force
muscles of different groups. N=6ormore and * indicates p b 0.05. The amount of initial maxim
time measurements to reach half maximal force was measured for EDL muscle in each group. N
tween soleusmuscles of different groups. N=6 ormore and * indicates p b 0.05. The amount of
plot showing time measurements to reach half maximal force was measured for soleus musclelonger duration than the EDL muscles. These results are in conformity
with the previous ﬁndings and are true to their nature with regard to
the main source of metabolism (oxidative versus glycolytic). The force
generation from the wild type EDL and soleus were consistently higher
than those muscles from the CBS+/−mice when they were subjected
to same electric stimulus. Interestingly, we did not observe any signiﬁ-
cant difference in the EDL or soleus muscle weight or length between
the two groups. We also measured (2E and 2F) time to half maximal
force as an indirect indicator of fatigue after subjecting the isotonic
muscles for repeating stimulations at a constant frequency and ﬁeld
strength. In the majority of cases, the EDL and soleus muscles from
CBS+/− exhibited quicker reduction in contractile force when com-
pared to that of the wild type muscles. Even though the differences
were not signiﬁcant, these ﬁndings do suggest that there is a tendency
for higher fatigability in metabolically different muscles (EDL and
soleus) of CBS+/−mice. Taken together, these ﬁndings suggest that ir-
respective of muscle ﬁber nature, HHcy exerts attenuated contractile
function and enhanced fatigability, at least as observed with the
ex-vivo scenario.
3.3. CBS+/−mice exhibit diminished muscle ﬁber size
To assess if there are any morphological changes that are associated
with HHcy condition, we performed H& E staining on the cross sections
of CBS+/− and wild type gastrocnemius muscles. No apparent gross
morphological differences such as damaged muscle ﬁbers or excessive
cell inﬁltration were noted between the groups (Fig. 3a). Next, we
assessed muscle ﬁber cross sectional area between the groups. As
shown in Fig. 3b, there was a signiﬁcantly higher number of mediumh experiments. (A) and (B) Representativemyobath tracings from EDL and Soleusmuscles
generation in grams. (C) Box plot depicting quantiﬁcation of force difference between EDL
al force generatedwas used for quantiﬁcation from each experiment. (D) Box plot showing
= 6 or more and p = 0.066. (E) Box plot depicting quantiﬁcation of force difference be-
initial maximal force generatedwas used for quantiﬁcation from each experiment. (F) Box
in each group. N = 6 or more and p = 0.05.
Fig. 3. Skeletalmusclemorphology andmuscleﬁber size enumeration. (A) Images of H & E
stained representative cross sections of gastrocnemius muscles were showed. The
magniﬁcation is 10×. (B) Bar graph and table showing different frequencies of muscle ﬁ-
bers categorized based on their size. Cross sectional area was calculated for ~350 muscle
ﬁbers from theH& E stained sectionsweremeasured using ImageJ software. Five different
animals were used. * indicates signiﬁcant difference (p b 0.05).
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reduction in the number of large muscle ﬁbers in CBS+/−mice. These
results suggest that HHcymight hinder formation of large muscle ﬁbers
and result in diminished muscle performance.
3.4. No signiﬁcant change in the levels of key enzymes involved in aerobic
and anaerobic metabolism
As the CSA of muscle ﬁbers does not always represent diminished
force production and fatigability [35], we assessed whether the ob-
served reduced performance and the declined muscle contractionFig. 4. Expression of differentmetabolic enzymes and tissue ATP levels. (A) Bar graph representi
muscles. β-actin levels were used to normalize input RNA amount across samples. (B) Bar grap
levels are non-signiﬁcant between the groups. β-Actin levels were used to normalize input RN
soleus muscle with and without exercise among groups. * indicates p b 0.05.force in CBS+/−mice are due to changes in key regulators of energy
metabolism. For that we assayed for mRNA levels of enzymes involved
in both aerobic and anaerobic metabolism. Though, the levels of
Cytochrome C Oxidase subunit IV (COX-IV) and lactate dehydrogenase
were less in CBS+/− mice skeletal muscles than in the wild type
mice the changes are not signiﬁcant enough to cause any considerable
degree of aerobic or anaerobic metabolic alterations respectively
(Fig. 4A). The levels of another key aerobic metabolic regulator, citrate
synthase, between the groups were barely changed (Fig. 4A). Next, to
know if there are any changes in the energy buffering capacity of the
skeletal muscles, the mRNA levels of muscle speciﬁc creatine kinase
(MM-CK) were measured. As depicted in Fig. 4B, there were no signiﬁ-
cant differences in theMM-CK levels betweenWT and CBS+/−mouse
muscles. When considered together, these ﬁndings suggest that the
differences in muscle force and animal performance between the
groups were not due to changes in the key metabolic regulators.
3.5. CBS+/− skeletal muscles exhibit reduction in ATP levels and exercise
restores them
To know if there are any changes in ATP levels which are the main
currency for the cell function, we assayed for the levels of ATP in the so-
leusmuscles between wild type and CBS+/−mice. Interestingly, there
was considerable decrease in ATP levels in the CBS+/−mice muscles
(Fig. 4C). Since, exercise has been shown to improve muscle health
and functional capacity; we asked whether exercise can restore ATP
levels in the CBS+/−mice skeletalmuscles. As shown in (Fig. 4C),mus-
cles from both groups contained enhanced ATP level presence after
4 weeks of administration of a swim exercise protocol. These ﬁndings
gave us indications that HHcy might compromise either mitochondrial
function or biogenesis and is responsible for the lower ATP production
in CBS+/−mice, as mitochondrial oxidation is the biggest contributor
to cellular ATP production.
3.6. CBS+/− mice exhibit decline in structural and mitochondrial
transcriptional regulators
As skeletal muscle fatigue could be due to structural and/or mito-
chondrial biogenesis regulation,we then assessed if any of these protein
levels are different between wild type and CBS+/− mice skeletal
muscles. Since dystrophin plays a crucial role in the determination of
skeletal muscle health, we looked at the levels of dystrophin in skeletal
muscles. As observed in Fig. 4A, Western blot data suggested that
although the dystrophin protein levels vary among each group, over
all we tend to see a declining trend in CBS+/−mice muscles. We alsong relative quantiﬁcation ofmRNA levels of CS, LDHand COX-IV between groups in skeletal
h depicting the levels of creatine kinase (muscle speciﬁc) mRNA between the groups. The
A amount across the samples. (C) Bar graph showing quantiﬁcation of tissue ATP levels in
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replication and biogenesis. Though there was no change in the mito-
chondrial fusion protein, Mfn2, levels between groups, the levels of mi-
tochondrial transcriptional/replication regulator, mtTFA, signiﬁcantly
declined in the CBS+/−mice group. Interestingly, the swim protocol
was able to restore mtTFA levels but failed to augment levels of
dystrophin in CBS+/− mice. Considering that dystrophin levels in
both groups were not signiﬁcantly improved after exercise, our results
suggest that exercise may produce a marginal inﬂuence on the levels
of dystrophin, if any, with our protocol. In contrast to the dystrophin
levels, exercise was able to restore mtTFA levels considerably.
Given that exercise was also able to enhance muscle ATP content in
CBS+/−mice, it is plausible that HHcy, by inhibiting levels of mtTFA,
is rendering the CBS+/−mice muscles more susceptible to fatigue.3.7. Exercise ameliorated changes in microRNA levels that were aberrant in
CBS+/−mice
Since exercise, by a multitude of effects including epigenetic
changes, could enhance skeletal muscle health and function and HHcy
was also reported to modulate epigenetic regulators, next we asked
the question: are there any microRNAs that regulate dystrophin and
mitochondrial function that are also known to be inﬂuenced by exercise.
Based on the literature search, we came across three speciﬁcmicroRNAs
(mir-31, mir-494 and mir-499) that were known to be expressed in
skeletal muscles and previously have been shown to inﬂuence either
dystrophin levels or modulate mitochondrial function [36–40]. We
quantiﬁed the levels of these microRNAs in total RNA samples between
wild type and CBS+/−mice with or without exercise.
As shown in Fig. 5, out of the threemicroRNAs assayed, mir-494was
expressed in higher amounts, followed bymir-31. The expression levels
of mir-499 were substantially declined. We found that mir-494 levelsFig. 5.Quantiﬁcation of relative concentration of different proteins affecting fatigability by
Western blotting. (A) Western blot image depicting changes in amounts of dystrophin,
mtTFA and Mfn2 in whole cell lysates of muscle tissues. The levels of GAPDH were used
to normalize input protein levels among the samples. Sampleswere derived from gastroc-
nemius muscles of sedentary and exercised mice. (B) Bar graph showing quantiﬁcation of
the above data. * indicates p is b0.05. ForMfn2 expression nomeasurable differenceswere
noticed.were signiﬁcantly higher in CBS+/− mice skeletal muscles and after
4 weeks of exercise the levels were signiﬁcantly reduced. The exercise
induced reduction inmir-494 levelswasminimal inwild type. Nonethe-
less, the mir-494 expression levels were negatively correlated with
mtTFA protein levels with and without exercise in CBS+/− mice.
These results suggest that HHcy might diminish mtTFA levels through
augmentation of mir-494 levels and that exercise reverses these HHcy
induced changes and restores proper muscle function. In addition to
mir-494 levels, we also observed a signiﬁcant increase in mir-31 levels
which was previously shown to negatively modulate dystrophin levels
in CBS+/− skeletal muscles. Though a negative relationship between
mir-31 levels and dystrophin was observed in CBS+/−mice, no such
relation was observed after exercise, even though mir-31 levels
dropped signiﬁcantly after exercise.
3.8. HHcy is also associated with diminished NRF-1 levels
Given that mtTFA expression can also be regulated at the transcrip-
tional level [41], we also veriﬁed if there are any changes in known
mtTFA transcriptional regulators such as NRF-1. Quantiﬁcation of
mRNA levels of NRF-1 (Fig. 6D) revealed that HHcy signiﬁcantly attenu-
ated NRF-1 mRNA. As reported before that exercise can enhance NRF-1
levels [42], NRF-1 levels were elevated after exercise in both groups and
were also correlated with enhanced mtTFA levels after the exercise
regimen. These ﬁndings together with the above results (Fig. 6A) indi-
cated that HHcy induced changes target expression of mtTFA at both
the transcriptional (declined NRF-1 level) and post transcriptional
levels (through increase in mir-494 level).
3.9. Treatment of C2C12 cells with Hcy reduced mtTFA levels and enhanced
mir-494 levels
To further determine if the observed changes in mir-494 and mtTFA
levels in CBS+/− skeletal muscles were due to HHcy and to test the
cause and effect relationship, we treated C2C12 cells as described in
theMaterials andmethods section. As shown in Fig. 7A and B, Hcy treat-
ment signiﬁcantly decreased mtTFA protein levels. Moreover, we also
observed enhancement of mir-494 levels after Hcy treatment in
C2C12 cells (Fig. 7C). These ﬁndings not only corroborate the previous
ﬁndings but also suggest that Hcy, when in excess, can alter mir-494
expression and thereby diminish mtTFA protein and compromise
muscle function.
3.10. Hcy treatment alters global methylation levels through enhancing
de novo methylation enzymes
Since HHcy could potentially alter other epigenetic patterns such as
CpG methylation, chromatin condensation apart from changes in
microRNA levels and inﬂuencing proper cell function, we tested if Hcy
treatment results in changes in other forms of epigenetic patterns. As
observed in Fig. 8, after three days of Hcy treatment, there was signiﬁ-
cant enhancement in the levels of two different mediators of de novo
DNA methylation enzymes: DNT3a and DNMT3b. Although there was
an enhancement in the levels of H3K18 acetylation levels after Hcy
treatment, the changes were not signiﬁcant. These results together
suggest that Hcy induces changes in DNA methylation patterns which
might also potentially inﬂuence gene expression related to muscle
function.
4. Discussion
Our data from the whole animal swim test and ex-vivo muscle con-
tractility measurements suggested that HHcy could diminish skeletal
muscle performance. Given that both oxidative and glycolytic muscles
are equally affected, we do not think that the HHcy induced changes
are ﬁber speciﬁc alterations. In addition, there were no apparent gross
Fig. 6.Quantiﬁcation of relativemicroRNA concentrations in the skeletalmuscles ofWT and CBS+/−micewith andwithout exercise. (A) Bar graph represents relative amount ofmir-494
expressed. **p b 0.01 and *p b 0.05. In case of wild type we could not observe signiﬁcant change in mir-494 after exercise. (B) Bar graph represents relative amount of mir-31 expressed.
**p b 0.01 and *p b 0.05. In the case of wild type, we could not observe any signiﬁcant change inmir-31 after exercise. (C) Bar graph represents relative amount of mir-499 expressed. No
signiﬁcant changes inmir-499 concentrations were observed among different groups. (D) Bar graph showing relative quantities of NRF-1 transcription factor in each group as assayed by
Q-PCR. * indicates p b 0.05. ** indicates p b 0.01.
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were differences in cross sectional area of the muscle ﬁbers. In
CBS+/−mice, there were more medium sized ﬁbers instead of larger
muscle ﬁbers observed with the wild type muscles. Though there is
some correlation between increase in muscle ﬁber CSA and physical
performance, the correlation is not solid. For example, inhibition of
myostatin receptor through chemical means resulted in enhanced CSA
but with diminished speciﬁc force [35]. Hence, mere reduction in mus-
cle ﬁber CSA may not account for the observed changes in the physical
performance and muscle contractile force.
To further characterize underlying molecular changes during HHcy
induced fatigability, we considered alterations in metabolic, structural
and mitochondrial function as potential starting points. Accordingly,
we measured levels of certain key enzymes that regulate aerobic and
anaerobicmetabolism and found no signiﬁcant changes (Fig. 3A). Previ-
ous studies have found that there was signiﬁcant elevation of MM-CK
levels in the plasma from the hyperhomocysteinemic rats indicating
HHcy inﬂicted muscle damage [43]. Our results suggest that there was
no signiﬁcant difference in the creatine kinase levels between WT and
CBS+/−mousemuscles implying no apparent imbalance in the energy
homeostasis. Together our ﬁndings demonstrate that there were no
signiﬁcant alterations in the key enzymes that regulate muscle metabo-
lism. However, skeletal muscles form CBS+/− exhibited low levels of
ATP presence and the ATP levels were increased after 4 weeks of exer-
cise (Fig. 3B) indicating some problem with either energy production
or utilization during HHcy. One limitation of the current study is that
relative amounts of other glycolytic enzymes [phosphofructokinase,
hexokinase (HK)], as well as glycogenolytic enzyme (glycogen
phosphorylase) were not assessed. Though, glyceraldehyde phosphate
dehydrogenase mRNA levels were increased to some extent in theCBS+/− mice, the differences were not signiﬁcant (not shown).
Nonetheless, decreased ATP concentration and reduced propensity
for mitochondrial replication and transcription (lower levels of
mtTFA) together suggest that the mitochondrial function is compro-
mised during HHcy conditions. Furthermore, we showed that the
relative quantities of the negative regulator of mtTFA, mir-494, were
increased in CBS+/−mice. Interestingly, exercise was able to reverse
the concentrations of mtTFA and mir-494, especially in CBS+/−mice.
These resultswould suggest amodelwhere inHHcymediated epigenet-
ic changes might augment mir-494 concentration and diminish mtTFA
amount and thereby compromise ATP production and attenuatemuscle
contractile properties, whereas regular exercise, by preventing mir-494
level augmentation during HHcy, could potentially ameliorate fatigabil-
ity. Other studies also reported involvement of mir-494 and mtTFA in
skeletal muscle function and in general our results conform to these
previous reports [16,37].
Alterations in mitochondrial biogenesis were also reported to cause
diminished skeletal muscle performance and enhanced fatigability. In
the current study we also examined if there were any alteration in
mitochondrial biogenesis, speciﬁcally in the quantities of the regulator
of mitochondrial fusion, Mfn2. Neither the exercise regimen we
employed nor the HHcy condition was able to perturb the amount of
Mfn2 in skeletal muscles. However, with our current study we could
not rule out the possibility that HHcy might alter the mitochondrial
ﬁssion and derail the healthy mitochondrial pool in skeletal muscles.
Nonetheless, relative amounts of mir-499, which targets Drp-1 and a
known regulator of mitochondrial ﬁssion [40], were not signiﬁcantly
altered in CBS+/−mice. This might argue against the possible role of
mitochondrial ﬁssion regulators in the fatigability of CBS+/−mice at
least through mir-499.
Fig. 7. Treatment of C2C12 cells with Hcy alters mir-494 and mtTFA levels. (A) Western
blot image showing mtTFA levels after 0.5 mM Hcy treatment. Equal loading was shown
by detecting GAPDH levels. (B) Bar graph represents quantiﬁcation of mtTFA levels from
Western blots. *p b 0.05. (C) Bar graph showing Q-PCR analysis of mir-494 relative
concentrations. *p b 0.05.
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injury and fatigability. Here we examined quantities of one such candi-
date, dystrophin, most frequently altered in human myopathies, in
CBS+/− andwild typemice. Thoughwewere able to observe differen-
tial expression of dystrophin between groups, the concentrations varied
among each group. Currently, we have no explanation for such variabil-
ity among the individuals. Nonetheless, consistent with the declining
tendency of dystrophin levels in the CBS+/−mouse muscles, a previ-
ous report has found that HHcy inﬂictsmuscle damage as therewas sig-
niﬁcant accumulation of MM-CK in the plasma which was correlated
with elevated Hcy levels [43]. Given that dystrophin deﬁciency is
frequently associated with MM-CK release from the muscles [44], our
current ﬁnding with the previous results [43] suggest that HHcy medi-
ated inhibition of dystrophin expression might be the reason behind
the muscle damage and elevation in the plasma MM-CK [43]. Apart
from apparent dystrophin level reduction in CBS+/−mouse muscles,
another potential mechanism that might damage muscles during
HHcy condition is heightened oxidative stress which may damage the
sarcolemmal membrane. Our unpublished results along with otherFig. 8. Changes in epigenetic patterns andmodiﬁers after Hcy treatment in C2C12 cells. (A) Rep
ylationmodiﬁcation after Hcy treatment. (B) Bar graph showing quantiﬁcation ofWestern data
sented in bar graph. * represents p b 0.05.data from different organ systems including skeletal muscles during
HHcy condition, may point to the compromised oxidative stress han-
dling during HHcy condition [8,45]. Further, oxidative stress has been
implicated with fatigue, and mitochondrial dysfunction as well [46].
Considering that moderate exercise and HHcy both increase oxidative
stress [8,47], it is still not clear how the HHcy condition differs from
exercise. It could be the intensity and/or persistence of oxidative stress
along with the other changes reported (epigenetic) in this manuscript
that could contribute to the fatigue. Other potential mechanisms in-
volve Ca2+mishandling whichmight lead to fatigue as well [48]. Future
studies will clarify more on these possibilities.
With 4 weeks of exercise we were unable to observe any signiﬁcant
change in dystrophin quantities in both groups. Inability of exercise
to alter dystrophin protein amount was reported before in humans
and our ﬁndings further corroborate this conclusion [49]. Though we
were able to observe a negative correlation between the amounts of
dystrophin and mir-31 in CBS+/−mice, the correlation was lost after
exercise. This ﬁnding contrasts the previous ﬁnding that mir-31
regulates dystrophin protein levels [39]. Though previous reports docu-
mented the negative correlation between exercise and levels of mir-31
and mir-494, in our study only mir-31 behaved in such fashion in
CBS+/− mice [37,38]. The apparent differences observed here could
be due to differences in intensity or duration of exercise regimen
employed. Interestingly, in addition to lack of exercise inﬂuence over
mir-499 quantities, we noted that this particularmicroRNA is expressed
in very low amounts in both groups further downgrading its ability to
mediate any physiological responses in skeletal muscles. In addition
mir-499 expression might have very well diminished in differentiated
matured muscles, as its expression is regulated by the myogenic tran-
scriptional factors such as MyoD [50], suggesting its limited role during
the muscle differentiation phase.
Modiﬁcations in epigenetic patterns have been proposed before, but
not tested to have a causal role in fatigue [13]. Here we show that HHcy
mediated epigenetic changes could potentially undermine skeletal
muscle ability to function. The potential ramiﬁcation from the current
study is enhanced DNA methylation and increased expression of
DNMT3 isoforms which might change gene expression either directly
by regulating transcription of mtTFA or indirectly through upregulation
of microRNAs. Here we have characterized one such negative associa-
tion between mtTFA and mir-494 during HHcy. Our current study
could not rule out changes in other potential mtTFA targeting
microRNAs. In addition, indirect regulation might also occur through
changes in levels of transcription factors such as PGC-1α and NRF-1
that regulate mtTFA expression and mitochondrial biogenesis [41]. In
our previous study, we could not observe any signiﬁcant change in the
amounts of PGC-1α between intact C57 and CBS+/− mice [34]. The
current study observed a signiﬁcant decrease in NRF-1 mRNA expres-
sion in HHcy mice in addition to enhanced mir-494. These ﬁndingsresentativeWestern blot image showing relative amounts of DNMT3a, 3b and H3K18 acet-
from (A). *p b 0.05. (C) Global 5methylcytosine levels were assayed by ELISA and are pre-
740 S. Veeranki et al. / Biochimica et Biophysica Acta 1852 (2015) 732–741together suggested orchestration of concerted multi-pronged changes
during HHcy leading to reduced mtTFA levels and mitochondrial
function to cause enhanced fatigability. Currently, the mechanisms of
NRF-1 down regulation during HHcy are not determined. It is also
possible that mir-31 and mir-494 might affect other targets not studied
here that could cause fatigability. Future studies will provide more
information with regard to these possibilities.
Other potential mechanisms with regard to enhancement of ATP
concentrations after exercisemight beworth considering, but not tested
in the current study are: 1) it was previously reported that exercise al-
leviates plasma Hcy levels by enhancing the BHMT levels in kidney
[51–53]. The reduction in Hcy levels might potentially reverse adverse
inﬂuence on mtTFA levels and restore proper mitochondrial function
and ATP levels. 2) Exercise has been shown to enhance PGC-1α and
NRF (Fig. 6D) transcription factors which might enhance mtTFA levels/
function and thereby counter the HHcy induced decline in mtTFA levels
[42]. 3) It is also possible that a combination of the above two possibil-
itiesmight also confer the observed effects. Future studieswould render
more details with regard to which of these aspects are in place after
exercise in reversal of HHcy mediated diminished performance.
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